Current status of genetics research in inflammatory bowel disease
Authors:
Open Access
- 18 August 2005
- journal article
- review article
- Published by Springer Nature in Genes & Immunity
- Vol. 6 (8) , 637-645
Abstract
The research on genetic susceptibility of inflammatory bowel diseases (IBD) has been tremendous and over 10 chromosomal regions have been identified by genome-wide scanning. Further fine mapping as well as candidate gene studies have already led to the identification of a number of susceptibility genes including CARD15, DLG5, OCTN1 and 2, NOD1, HLA, and TLR4. The CARD15 gene is undoubtedly replicated most widely and most understood at present. CARD15 is involved in the recognition of bacterial peptidoglycan-derived muramyl dipeptide (MDP) and will stimulate secretion of antimicrobial peptides including alpha-defensins (also called cryptdins) to protect the host from invasion. Genetic research in IBD has advanced our understanding of the clinical heterogeneity of the disease and has started to tackle the complex interactions between genetic risk factors and environmental risk factors in IBD. Genes also interfere with the metabolization of drugs and may influence the clinical response and the drug-related toxicity. Interesting pharmacogenetic data with respect to steroids, azathioprine, and infliximab have been generated in IBD. Overall, it is anticipated that genetic markers in the future will be implemented in an integrated molecular diagnostic and prognostic approach of our patients.Keywords
This publication has 108 references indexed in Scilit:
- DLG5 variants do not influence susceptibility to inflammatory bowel disease in the Scottish populationGut, 2005
- The International HapMap ProjectNature, 2003
- IBD5 is a General Risk Factor for Inflammatory Bowel Disease: Replication of Association with Crohn Disease and Identification of a Novel Association with Ulcerative ColitisThe American Journal of Human Genetics, 2003
- Analysis of the IBD5 locus and potential gene-gene interactions in Crohn’s diseaseGut, 2003
- Genetic Evidence for Interaction of the 5q31 Cytokine Locus and the CARD15 Gene in Crohn DiseaseThe American Journal of Human Genetics, 2003
- Genome-wide search in Finnish families with inflammatory bowel disease provides evidence for novel susceptibility lociEuropean Journal of Human Genetics, 2003
- Induction of Nod2 in Myelomonocytic and Intestinal Epithelial Cells via Nuclear Factor-κB ActivationJournal of Biological Chemistry, 2002
- Inflammatory Bowel Disease A Positive Response to Infliximab in Crohn Disease: Association with a Higher Systemic Inflammation Before Treatment But Not With -308 TNF Gene PolymorphismScandinavian Journal of Gastroenterology, 2002
- Nod2, a Nod1/Apaf-1 Family Member That Is Restricted to Monocytes and Activates NF-κBJournal of Biological Chemistry, 2001
- cDNA Sequence, Transport Function, and Genomic Organization of Human OCTN2, a New Member of the Organic Cation Transporter FamilyBiochemical and Biophysical Research Communications, 1998